ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981